Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | G6PD | P11413 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208161 | 0.83 | KDM4E (0.53) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL2930434 | 0.83 | KDM4E (0.50) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL26963264 | 0.82 | SELL (0.56) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL29860864 | 0.82 | SELL (0.56) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL1149742 | 0.81 | KDM4E (0.48) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL30083685 | 0.80 | ALDH1A1 (0.65) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL857301 | 0.80 | ALDH1A1 (0.65) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL27449542 | 0.79 | KDM4E (0.47) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL2264689 | 0.79 | KDM4E (0.47) | KDM4EALDH1A1HPGDHSD17B10G6PD | |
| SCHEMBL10800974 | 0.79 | KDM4E (0.47) | KDM4EALDH1A1HPGDHSD17B10G6PD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116472292-A | Modified proteins and protein degrading agents | 上海睿跃生物科技有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20220090100-A1 | METHOD FOR PRODUCING COMPOUND WITH MODIFIED MOTHER NUCLEUS | JAPAN BIOLOGICAL INFORMATICS CONSORTIUM (JP) | 2022-03-24 | — | — | US | disclosed |
| WO-2020158839-A1 | METHOD FOR PRODUCING COMPOUND WITH MODIFIED MOTHER NUCLEUS | 一般社団法人バイオ産業情報化コンソーシアム | 2020-08-06 | — | — | WO | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| CN-108929865-A | A method of induction Produced from Pleurotus ostreatus accelerates to produce laccase | 北京林业大学 | 2018-12-04 | — | — | CN | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-9656971-B2 | COMT inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2017-05-23 | — | — | US | disclosed |
| EP-0513543-B1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE AG (DE) | 1995-10-25 | — | — | EP | disclosed |
| US-5457114-A | Antithrombin; antithrombotic, enzyme resistance, tolerability | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1995-10-10 | — | — | US | disclosed |
| EP-0643686-A1 | NEW COMPOUNDS | Astra Aktiebolag (SE) | 1995-03-22 | — | — | EP | disclosed |
| WO-1993005012-A1 | NEW COMPOUNDS | AB ASTRA (SE) | 1993-03-18 | — | — | WO | disclosed |
| EP-0530166-A2 | 3-Hydroxy anthranilic acid derivatives for inhibiting 3-hydroxy anthranilate oxygenase | Astra Aktiebolag (SE) | 1993-03-03 | — | — | EP | disclosed |
| CN-1067249-A | Amidinophenylalaninederivatives derivatives and Preparation Method And The Use | BEHRINGWERKE AG (DE) | 1992-12-23 | — | — | CN | disclosed |
| EP-0513543-A1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | disclosed |
| EP-0148752-B1 | PROTEASE INHIBITORS | G.D. Searle & Co. (US) | 1989-06-21 | — | — | EP | disclosed |
| US-4551279-A | Protease inhibitors | G. D. SEARLE & CO. (US) | 1985-11-05 | — | — | US | disclosed |
| EP-0148752-A2 | Protease inhibitors | G.D. Searle & Co. (US) | 1985-07-17 | — | — | EP | disclosed |